Chi-Med Reports 2020 Interim Results and Provides Updates on Key Clinical Programs

Ads

You May Also Like

The Biologics Market is Expected to Witness a CAGR of 9.9% to Reach $441.5 Billion by 2024

Global Biologics Market Drivers, Opportunities, Trends, and Forecasts 2024Bangalore, Aug. 08, 2018 (GLOBE NEWSWIRE) ...

Aduro Biotech to Present at Two Investor Conferences in March

BERKELEY, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...